The medium was then replaced with medium containing 0.5% FBS for 24 h. The 201 proliferation responses were monitored using an MTT (3-(4, 5-dimethylthiazolyl-2)-2, proliferation, and wound healing experiments that have more than two groups.
227
Statistical analysis was performed using GraphPad Prism software.
228

Results
229
Gingipain activity of P. gingivalis. In this study, we used gingipain substrates and a 230 fluorescence assay to validate the activity of gingipains in different P. gingivalis 231 strains. As expected, E8 showed only Kgp activity and K1A showed only Rgp 
267
The wild type strain P. gingivalis 381 and its corresponding major fimbriae mutant 268 DPG3 and minor fimbriae mutant KRX178 significantly down-regulated the gene 269 expression of Angpt1 in AoSMCs after 24h ( Fig. 2A ). All three of these strains of P. The TNF ELISA kit detects human TNF levels from 7.8 pg/ml to 500 pg/ml.
287
However, the TNF levels in the supernatants from AoSMCs treated with the P. AoSMCs after 16 and 24 h (Fig. 4A) . Compared with W50, the Rgp and Kgp mutant 293 strains E8 and K1A, respectively, had no effect on ETS1 gene expression. Inhibition 294 of Rgp with Leupeptin, significantly antagonized the stimulatory effect of W50 ( Fig.   295 S2C). The wild type strain 381 and its fimbriae mutants, DPG3 and KRX178, 296 significantly increased ETS1 expression in AoSMCs after 24 h (Fig. 4B ). TNF also 297 significantly increased the expression of ETS1 in AoSMCs after 24h when applied at 298 a concentration of 10 ng/ml and 50 ng/ml (Fig. 4C ). Compared with wild type P. 299 gingivalis and TNF, F. alocis showed no effect on ETS1 gene expression after 24 h 300 ( Fig. S3 ). To ensure that the up-regulation of ETS1 by P. gingivalis infection was 301 correlated with the up-regulation of Angpt2 in AoSMCs, we performed an ETS1 302 siRNA knock down experiment. We found that the ETS1 siRNA significantly 303 reduced the up-regulation of ETS1 in AoSMCs that were treated with P. gingivalis 304 W50 (Fig. 5A ). This result confirms our finding by showing that the up-regulation of 305 Angpt2 at the mRNA (Fig. 5B ) and protein levels ( Fig. 5C and 5D ) by W50 is 306 significantly reduced in ETS1 siRNA knock down AoSMCs. assays showed that Angpt2 has no effect on AoSMCs proliferation (Fig. 6A ).
311
However, Angpt2 protein dose-dependently increased the migration of AoSMCs in 312 cells analyzed with the scratched assay. After 18 h, cells stimulated with 100 ng/ml or 313 500 ng/ml of Angpt2 protein covered almost the entire scratched area ( Fig. 6B and 6C) . In our previous study, 25 we found that the amount of LPS that was produced and 365 released differed between various bacterial strains. Consequently, we studied how LPS Angpt2, we exposed AoSMCs to various doses of TNF. We found that TNF inhibited 378 the expression of Angpt1 but increased the expression of Angpt2 in AoSMCs. These 379 effects are similar to those obtained in AoSMCs that were stimulated with P. 380 gingivalis. However, TNF was not detected in the supernatants of AoSMCs that were 381 stimulated with P. gingivalis, which indicates that P. gingivalis-mediated regulation 382 of Angpt1 and Angpt2 in AoSMCs is independent of TNF.
383
Because we found that P. gingivalis and TNF dramatically increase the expression of 384 the Angpt2 gene in AoSMCs, we further examined the gene expression of ETS1, the 385 transcription factor of Angpt2. 56, 57 Wild type, fimbriae mutant of P. gingivalis, and 386 TNF increased the expression of the ETS1 gene, respectively, which was then 387 correlated with the effects on Angpt2. However, the RgpA/B mutant E8 was unable to In summary, we found that P. gingivalis infection induces comparable effects on the 401 expression of Angpt1, Angpt2, and ETS1 in AoSMCs, and gingipains are crucial for 402 this regulation. However, the cardiovascular risk factor TNF is not involved. In 403 combination with observed cellular effects, our findings suggest that Angpt2 plays a 404 role in the association between periodontitis and atherosclerosis. and its corresponding gingipain mutants (E8 and K1A) and to Prof. Genco RJ and Prof. 
